← Open Payments lookup

LAURIE COLE: Open Payments

NPI 1407102296 · BRYN MAWR, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$653 in 24 payments from 11 companies in 2025. Trend: 2023 $693 · 2024 $479 · 2025 $653

Food & beverage: $653
CompanyPaymentsAmount
Janssen Biotech, Inc.4$217
ABBVIE INC.5$97
Sumitomo Pharma America, Inc.3$62
AstraZeneca Pharmaceuticals LP2$49
BIOPROTECT MEDICAL, INC.1$48
UROGEN PHARMA, INC.2$43
Ferring Pharmaceuticals Inc.2$37
Endo USA, Inc.2$35
PFIZER INC.1$25
Merck Sharp & Dohme LLC1$24

Products named: ERLEADA, GEMTESA, BOTOX, LYNPARZA, BIOPROTECT BALLOON IMPLANT SYSTEM, LUPRON DEPOT, ADSTILADRIN, XIAFLEX.

Industry payments across PA — which companies pay providers there.